Detoit, Michigan
Otsu, Shiga
Recruiting
Otsu, Shiga
Recruiting
Otsu, Shiga
Recruiting
Otsu, Shiga
Recruiting
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
Phase
3Span
271 weeksSponsor
Bristol-Myers SquibbOtsu, Shiga
Recruiting
Otsu, Shiga
Recruiting
1-6 of 6